Pre-IPO China Medical System (867 HK) - About the IPO in Singapore and Concerns on Valuation Outlook
Listing in SGX opens a new chapter and CMS is undergoing pipeline adjustments and strategic transformation. But as valuation logic changes, license...
499 Views
Innovent Biologics Placement - Second for the Month, Stock Has Doubled but Momentum Is Strong
Innovent Biologics Inc (1801 HK) aims to raise around US$500m for R&D and marketing. In this note, we talk about the deal dynamics.
617 Views
Sichuan Kelun-Biotech Biopharm (6990.HK) Placement - Thoughts The Pipeline and Valuation Outlook
Kelun Bio's HK$331.8/share Placing price is expensive.Valuation should be higher than Akeso.Buy when valuation falls in US$2.5-5.25 billion...
510 Views
ECM Weekly (9 June 2025) - Haitian, Sanhua, Virgin Aus, Primo, Kitazato, Wistron, Kelun Bio, Mao Gep
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
635 Views
Kelun-Biotech Placement - Recent Run-Up Makes Its Tricky
Kelun-Biotech Biopharmaceutical Co (Kelun) is looking to raise up to US$200m from a primary placement. In this note, we will talk about the...
523 Views